HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of insulin-like growth factor 2 mRNA-binding protein 3 as a radioresistance factor in squamous esophageal cancer cells.

Abstract
Identification of reliable markers of radiosensitivity and the key molecules that donate susceptibility to anticancer treatments to esophageal cancer cells would be highly desirable. We found that the mRNA expression of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) was higher in radioresistant TE-5 and TE-9 cells than in radiosensitive TE-12 cloneA1 cells. Conversely, knocking down expression of IGF2BP3 mRNA in TE-5 and TE-9 cells using small interfering RNA significantly enhanced their radiosensitivity. Furthermore, patients with squamous cell esophageal cancers strongly expressing IGF2BP3 tended to respond poorly to chemoradiation. These data suggest that IGF2BP3 may be a key marker of radiosensitivity that diminishes the susceptibility of squamous cell esophageal cancer cells to radiotherapy. IGF2BP3 may, thus, be a useful target for improving radiotherapy for patients with esophageal squamous cell carcinoma.
AuthorsK Yoshino, S Motoyama, S Koyota, K Shibuya, Y Sato, T Sasaki, A Wakita, H Saito, Y Minamiya, T Sugiyama, J Ogawa
JournalDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus (Dis Esophagus) Vol. 27 Issue 5 Pg. 479-84 (Jul 2014) ISSN: 1442-2050 [Electronic] United States
PMID22989274 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.
Chemical References
  • IGF2BP3 protein, human
  • RNA, Messenger
  • RNA, Small Interfering
  • RNA-Binding Proteins
Topics
  • Carcinoma, Squamous Cell (metabolism, pathology, radiotherapy)
  • Cell Line, Tumor
  • Chemoradiotherapy
  • Esophageal Neoplasms (metabolism, pathology, radiotherapy)
  • Gene Knockdown Techniques
  • Humans
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering
  • RNA-Binding Proteins (genetics, metabolism)
  • Radiation Tolerance (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: